Youth Assigned Female at Birth No More Likely to Present as Trans
WEDNESDAY, Aug. 3, 2022 (HealthDay News) — The sex-assigned-at-birth ratio of transgender and gender-diverse (TGD) adolescents does not favor adolescents who were assigned female sex at birth (AFAB) versus those who were assigned male sex at birth …
Learn MoreBlack-White Disparities Persist for Cardiovascular Mortality
WEDNESDAY, Aug. 3, 2022 (HealthDay News) — Cardiovascular mortality is still increased for Black versus White adults, according to two studies published online July 18 in Circulation.Ashley N. Kyalwazi, from the Beth Israel Deaconess Medical Center i…
Learn MoreJust 8% of Americans Lack Health Insurance, a Record Low
WEDNESDAY, Aug. 3, 2022 (HealthDay News) — The number of Americans without health insurance continues to drop, reaching 8% in 2022 — a record low.That leaves about 26 million people living in America without health insurance. The announcement was ma…
Learn MoreEarly Warning System Can Identify Sepsis Patients
WEDNESDAY, Aug. 3, 2022 (HealthDay News) — An early warning system has the potential to identify sepsis patients early and improve patient outcomes, according to a study published online July 21 in Nature Medicine.
Roy Adams, Ph.D., from Johns Ho…
Learn MoreRecommendations Issued for Medical Response to Mass Shootings
WEDNESDAY, Aug. 3, 2022 (HealthDay News) — In an article published online July 18 in the Journal of the American College of Surgeons, recommendations are presented for the medical and surgical management of mass shooting incidents.Craig Goolsby, M.D….
Learn MoreRecommendations Issued for Medical Response to Mass Shootings
WEDNESDAY, Aug. 3, 2022 (HealthDay News) — In an article published online July 18 in the Journal of the American College of Surgeons, recommendations are presented for the medical and surgical management of mass shooting incidents.Craig Goolsby, M.D….
Learn MoreNeoadjuvant mFOLFIRINOX Studied for Borderline Resectable PDAC
WEDNESDAY, Aug. 3, 2022 (HealthDay News) — For patients with borderline resectable pancreatic ductal adenocarcinoma (PDAC), favorable overall survival was observed following treatment with eight cycles of neoadjuvant modified FOLFIRINOX (mFOLFIRINOX)…
Learn MoreNeoadjuvant mFOLFIRINOX Studied for Borderline Resectable PDAC
WEDNESDAY, Aug. 3, 2022 (HealthDay News) — For patients with borderline resectable pancreatic ductal adenocarcinoma (PDAC), favorable overall survival was observed following treatment with eight cycles of neoadjuvant modified FOLFIRINOX (mFOLFIRINOX)…
Learn MoreSubclinical Atherosclerosis More Likely Among Young Black Adults
WEDNESDAY, Aug. 3, 2022 (HealthDay News) — Socioeconomically vulnerable non-Hispanic Black young adults are more likely to have subclinical atherosclerosis than Hispanic young adults, according to a study published online in the July 19 issue of the …
Learn MoreSubclinical Atherosclerosis More Likely Among Young Black Adults
WEDNESDAY, Aug. 3, 2022 (HealthDay News) — Socioeconomically vulnerable non-Hispanic Black young adults are more likely to have subclinical atherosclerosis than Hispanic young adults, according to a study published online in the July 19 issue of the …
Learn More